chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AEs; expired MMR II was administered; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported.      On 14-APR-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) 0.5 mL, subcutaneously (SQ), Albumin status rHA lot # U007686 with expiration date 09-MAR-2023, for prophylaxis (strength was not provided). No additional adverse event (AE) was provided.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Bone pain, Chills, Dizziness, Headache
Clinical narrative: Couldn't get up out of bed or open her eyes on Saturday (day after the vaccination); Fever of 100.4 on Sunday; Sweating; Shivering; Arm is red at injection site; Could barely move her right arm; Queasy/nausea; Vomiting; feeling faint/Dizzy; Weak; Body aches (bones and muscle); Body aches; Body aches (bones and muscle); Headache; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number 97LJ7) for prophylaxis.  On 02-JUN-2023, the patient received the 1st dose of Shingrix (right arm). On 02-JUN-2023, 6 hrs after receiving Shingrix, the patient experienced injection site erythema (Verbatim: Arm is red at injection site), injected limb mobility decreased (Verbatim: Could barely move her right arm), queasy (Verbatim: Queasy/nausea), vomiting (Verbatim: Vomiting), felt faint (Verbatim: feeling faint/Dizzy), weakness (Verbatim: Weak), bone pain (Verbatim: Body aches (bones and muscle)), general body pain (Verbatim: Body aches), muscle pain (Verbatim: Body aches (bones and muscle)), headache (Verbatim: Headache), sweating (Verbatim: Sweating) and shivering (Verbatim: Shivering). On 03-JUN-2023, the patient experienced bedridden (Verbatim: Couldn't get up out of bed or open her eyes on Saturday (day after the vaccination)) and fever (Verbatim: Fever of 100.4 on Sunday). The outcome of the injection site erythema, injected limb mobility decreased, felt faint, weakness, bone pain, general body pain, muscle pain and headache were not resolved and the outcome of the queasy, vomiting, bedridden, sweating, shivering and fever were resolved.  It was unknown if the reporter considered the injection site erythema, injected limb mobility decreased, queasy, vomiting, felt faint, weakness, bone pain, general body pain, muscle pain, headache, bedridden, sweating, shivering and fever to be related to Shingrix.  It was unknown if the company considered the injection site erythema, injected limb mobility decreased, queasy, vomiting, felt faint, weakness, bone pain, general body pain, muscle pain, headache, bedridden, sweating, shivering and fever to be related to Shingrix.  Additional Information: GSK receipt date: 05-June-2023 and 06-JUN-2023 The consumer was the reporter. The patient received the first dose of Shingrix. On the day of vaccination at evening, the patient experienced queasy, nausea and vomiting, dizzy and felt faint.  The patient also was shivering and sweating. The patient experienced body aches in body and muscle, headache, and weak, arm was red at injection site and could barely move her right arm.. The patient could not get out of bed on Saturday or open her eyes.  The patient also experienced a fever on Saturday but was unable to find a thermometer to document the value and on Sunday she had a fever of 100.4 for the entire day. The reporter consented to follow up.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Hyperhidrosis, Injected limb mobility decreased, Injection site erythema, Mobility decreased, Myalgia
Clinical narrative: Couldn't get up out of bed or open her eyes on Saturday (day after the vaccination); Fever of 100.4 on Sunday; Sweating; Shivering; Arm is red at injection site; Could barely move her right arm; Queasy/nausea; Vomiting; feeling faint/Dizzy; Weak; Body aches (bones and muscle); Body aches; Body aches (bones and muscle); Headache; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number 97LJ7) for prophylaxis.  On 02-JUN-2023, the patient received the 1st dose of Shingrix (right arm). On 02-JUN-2023, 6 hrs after receiving Shingrix, the patient experienced injection site erythema (Verbatim: Arm is red at injection site), injected limb mobility decreased (Verbatim: Could barely move her right arm), queasy (Verbatim: Queasy/nausea), vomiting (Verbatim: Vomiting), felt faint (Verbatim: feeling faint/Dizzy), weakness (Verbatim: Weak), bone pain (Verbatim: Body aches (bones and muscle)), general body pain (Verbatim: Body aches), muscle pain (Verbatim: Body aches (bones and muscle)), headache (Verbatim: Headache), sweating (Verbatim: Sweating) and shivering (Verbatim: Shivering). On 03-JUN-2023, the patient experienced bedridden (Verbatim: Couldn't get up out of bed or open her eyes on Saturday (day after the vaccination)) and fever (Verbatim: Fever of 100.4 on Sunday). The outcome of the injection site erythema, injected limb mobility decreased, felt faint, weakness, bone pain, general body pain, muscle pain and headache were not resolved and the outcome of the queasy, vomiting, bedridden, sweating, shivering and fever were resolved.  It was unknown if the reporter considered the injection site erythema, injected limb mobility decreased, queasy, vomiting, felt faint, weakness, bone pain, general body pain, muscle pain, headache, bedridden, sweating, shivering and fever to be related to Shingrix.  It was unknown if the company considered the injection site erythema, injected limb mobility decreased, queasy, vomiting, felt faint, weakness, bone pain, general body pain, muscle pain, headache, bedridden, sweating, shivering and fever to be related to Shingrix.  Additional Information: GSK receipt date: 05-June-2023 and 06-JUN-2023 The consumer was the reporter. The patient received the first dose of Shingrix. On the day of vaccination at evening, the patient experienced queasy, nausea and vomiting, dizzy and felt faint.  The patient also was shivering and sweating. The patient experienced body aches in body and muscle, headache, and weak, arm was red at injection site and could barely move her right arm.. The patient could not get out of bed on Saturday or open her eyes.  The patient also experienced a fever on Saturday but was unable to find a thermometer to document the value and on Sunday she had a fever of 100.4 for the entire day. The reporter consented to follow up.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Couldn't get up out of bed or open her eyes on Saturday (day after the vaccination); Fever of 100.4 on Sunday; Sweating; Shivering; Arm is red at injection site; Could barely move her right arm; Queasy/nausea; Vomiting; feeling faint/Dizzy; Weak; Body aches (bones and muscle); Body aches; Body aches (bones and muscle); Headache; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number 97LJ7) for prophylaxis.  On 02-JUN-2023, the patient received the 1st dose of Shingrix (right arm). On 02-JUN-2023, 6 hrs after receiving Shingrix, the patient experienced injection site erythema (Verbatim: Arm is red at injection site), injected limb mobility decreased (Verbatim: Could barely move her right arm), queasy (Verbatim: Queasy/nausea), vomiting (Verbatim: Vomiting), felt faint (Verbatim: feeling faint/Dizzy), weakness (Verbatim: Weak), bone pain (Verbatim: Body aches (bones and muscle)), general body pain (Verbatim: Body aches), muscle pain (Verbatim: Body aches (bones and muscle)), headache (Verbatim: Headache), sweating (Verbatim: Sweating) and shivering (Verbatim: Shivering). On 03-JUN-2023, the patient experienced bedridden (Verbatim: Couldn't get up out of bed or open her eyes on Saturday (day after the vaccination)) and fever (Verbatim: Fever of 100.4 on Sunday). The outcome of the injection site erythema, injected limb mobility decreased, felt faint, weakness, bone pain, general body pain, muscle pain and headache were not resolved and the outcome of the queasy, vomiting, bedridden, sweating, shivering and fever were resolved.  It was unknown if the reporter considered the injection site erythema, injected limb mobility decreased, queasy, vomiting, felt faint, weakness, bone pain, general body pain, muscle pain, headache, bedridden, sweating, shivering and fever to be related to Shingrix.  It was unknown if the company considered the injection site erythema, injected limb mobility decreased, queasy, vomiting, felt faint, weakness, bone pain, general body pain, muscle pain, headache, bedridden, sweating, shivering and fever to be related to Shingrix.  Additional Information: GSK receipt date: 05-June-2023 and 06-JUN-2023 The consumer was the reporter. The patient received the first dose of Shingrix. On the day of vaccination at evening, the patient experienced queasy, nausea and vomiting, dizzy and felt faint.  The patient also was shivering and sweating. The patient experienced body aches in body and muscle, headache, and weak, arm was red at injection site and could barely move her right arm.. The patient could not get out of bed on Saturday or open her eyes.  The patient also experienced a fever on Saturday but was unable to find a thermometer to document the value and on Sunday she had a fever of 100.4 for the entire day. The reporter consented to follow up.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling, Pain in extremity
Clinical narrative: Small bump around injection site; Arm hurts; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 5YR3P, expiry date 17-JUN-2024) for prophylaxis.   On 14-MAR-2023, the patient received the 1st dose of Shingrix (intramuscular, left arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site swelling (Verbatim: Small bump around injection site) and pain in arm (Verbatim: Arm hurts). The outcome of the injection site swelling and pain in arm were not resolved.   It was unknown if the reporter considered the injection site swelling and pain in arm to be related to Shingrix.     It was unknown if the company considered the injection site swelling and pain in arm to be related to Shingrix.   Additional Information: GSK Receipt Date: 06-JUN-2023 The reporter was a pharmacy intern called on behalf of a patient that called the pharmacy to report that she received dose of Shingrix and her arm still hurt and there was a small bump forming around the injection site. The reporter had no further information to report about this event. The reporter consented to follow up. Consent to follow up with pharmacy about this was obtained.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Feeling hot, Injection site erythema, Injection site pain, Injection site rash
Clinical narrative: soreness at the injection site; developed redness; rash in left arm going down to elbow; reports her arm is hot; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 05-JUN-2023, the patient received the 1st dose of Shingrix (left arm). On 07-JUN-2023, 2 days after receiving Shingrix, the patient experienced injection site pain (Verbatim: soreness at the injection site), injection site erythema (Verbatim: developed redness), rash (Verbatim: rash in left arm going down to elbow) and hot feeling in hand (Verbatim: reports her arm is hot). The outcome of the injection site pain, injection site erythema, rash and hot feeling in hand were unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, rash and hot feeling in hand to be related to Shingrix.     It was unknown if the company considered the injection site pain, injection site erythema, rash and hot feeling in hand to be related to Shingrix.   Additional Information: GSK Receipt Date: 07-JUN-2023 The reporter reported that the patient received Shingrix and on day of reporting, she developed redness and soreness at the injection site, also reported her arm was hot and a rash in left arm went down to elbow.   Adverse Event was filed. The patient stated she had medical attention for that matter and was prescribed prednisone and antibiotics. The reporter consented to follow up.
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Feeling hot, Malaise
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Additional Details: patient was given shot by immuizing tech. patient and vaccine were both double verified with patient. A man with patient states she isnt feeling too well. immunizing tech lets pharmacist know. pharmacist sees patient, she states she is lighteheaded and feels warm. Patients presentation was inline with syncope reaction. cold water was offered and gotten for the patient. pharmacist stayed with patient 15M until patient stated she was feeling better. told patient to ask if anything else was needed
Age: 89.0
Sex: F
Vaccine: PNC20
Symptoms: Dizziness, Fatigue, Hypertension, Lethargy, Tremor
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Mild, Systemic: Hypertension-Medium, Systemic: Shakiness-Medium
Age: 39.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling, Paraesthesia
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: left hand tingling-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: left hand tingling
Age: 29.0
Sex: M
Vaccine: COVID19-2
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Site: Redness at Injection Site-Medium
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Symptom recurrence
Clinical narrative: LEFT BELLS PALSY 12/2/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 95.0
Sex: F
Vaccine: COVID19-2
Symptoms: Aphasia, Dyskinesia, Hypertension, Seizure like phenomena
Clinical narrative: patient started having seizure like activity.  nursing staff noticed her having jerking movements, started triaging patient.  Patients regular nurse for the day stated she had been acting off for the last few days.  Patient was not very cognitive when addressing her before giving her the vaccine which is not unheard of as she was on Memory support hall.  Patient was removed from the room and nursing director was going to get in touch with patients family to see what they wanted to do going forward.  Patient did become somewhat verbal but for only seconds at a time.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Pt. reported developing a persistent cough a week after receiving the vaccine that lasted multiple weeks. The patient states that he still is experiencing a minor cough at the time of reporting the event.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Pulmonary embolism
Clinical narrative: I26.99 ACUTE PULMONARY EMBOLISM 4/18/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM 4/25/2023 HX OF PULMONARY EMBOLUS
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pericardial calcification
Clinical narrative: I31.1 PERICARDIAL CALCIFICATION 4/28/2023 PERICARDIAL CALCIFICATION
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Pregnancy of unknown location
Clinical narrative: Pfizer vaccine was administered outside of facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED  ALLERGIC REACTION, INIT 3/7/2022 PREGNANCY OF UNKNOWN LOCATION ALLERGIC REACTION, INIT 3/7/2022 PREGNANCY OF UNKNOWN LOCATION
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Dysphagia, Hypoxia, Pulmonary embolism, Respiratory failure
Clinical narrative: I26.99 ACUTE PULMONARY EMBOLISM 5/3/2023 DYSPHAGIA J96.00 ACUTE RESPIRATORY FAILURE 5/3/2023 DYSPHAGIA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/4/2023 DYSPHAGIA R09.02 HYPOXIA 5/3/2023 DYSPHAGIA I26.99 ACUTE PULMONARY EMBOLISM 5/3/2023 DYSPHAGIA J96.00 ACUTE RESPIRATORY FAILURE 5/3/2023 DYSPHAGIA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/4/2023 DYSPHAGIA R09.02 HYPOXIA 5/3/2023 DYSPHAGIA
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Osteomyelitis
Clinical narrative: I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 4/1/2023 SUBACUTE OSTEOMYELITIS OF LEFT FOOT
Age: 72.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse events noted.  Documentation of COVID vaccine given in error. Per Immunization Registry, patient received a dose of Pfizer Bivalent on 10/12/22 at Pharmacy, was then give a dose of Pfizer bivalent on 10/17/22 at 9:11AM  at facility.   10/12/22 Pfizer was reconciled into patient's EMR on 10/17/22 at 3;09pm.   This was identified by report.
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Tremor
Clinical narrative: Patient experienced  tremors
Age: 57.0
Sex: M
Vaccine: VARZOS
Symptoms: Expired product administered
Clinical narrative: Employee received vaccination today.  However vaccine expired on 06/02/2023
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Symptom recurrence, Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA 11/14/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: OBSTRUCTIVE SLEEP APNEA 11/22/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, No adverse event, SARS-CoV-2 test negative, Upper respiratory tract infection
Clinical narrative: I did not have a reaction to the vaccine. I began not feeling well on 06/04/2023 and took a COVID-19 test. It was negative. I have an upper respiratory infection. I was not given an antibiotic because they believe it's bacterial. I was given a prescription for a steroid and an inhaler.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: No adverse event, Wrong patient received product
Clinical narrative: No adverse event. Patient received correct dose. An earlier patient with same first name received the vaccine under this patients name.. but both needed shingrix vaccines.
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypotension, Hypoxia, Respiratory failure, Shock, Symptom recurrence
Clinical narrative: HYPOTENSION ACUTE RESPIRATORY FAILURE HYPOXEMIA SHOCK, UNSPECIFIED 3/18/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 89.0
Sex: F
Vaccine: VARZOS
Symptoms: Administration related reaction, Arthralgia, Bursitis, Pain in extremity
Clinical narrative: sore arm and shoulder for several week, tried OTC nsaids etc..MD referred pt to Orthopedic MD and he believes pt has bursitis related to vaccine administration.  Gave steriod injection and referred to physical therapy
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Respiratory failure, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/2/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure
Clinical narrative: CHRONIC RESPIRATORY FAILURE
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Myocardial ischaemia
Clinical narrative: ACUTE NON ST ELEVATION MI  DEMAND ISCHEMIA
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ALLERGIC REACTION, INIT
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest X-ray normal, Chest pain, Cough, Oropharyngeal pain
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED & BOOSTED COVID POSITIVE. Patient was admitted to the hospital with multiple medical problems COVID 19 causing acute tracheo-bronchitis/pharyngitis,  Atypical chest pain. Pt presented to the emergency room with cough, sore throat, fever, chest pain for about 3 days.  He was vaccinated for COVID-19.  His COVID-19 test was positive.  He was noted to have oxygen saturation now of 99% on room air.  He is afebrile.  Patient was seen and evaluated by IM and multiple consultants including ID, after a aggressive medical management patient has improved clinically feels better and ready for discharge. Patient has been cleared by ID to transition to p.o. OMNICEF/ Medrol Dosepak. No additional treatment indicated for COVID-19.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pharyngitis, Pyrexia, SARS-CoV-2 test positive, Tracheobronchitis, Vaccine breakthrough infection
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED & BOOSTED COVID POSITIVE. Patient was admitted to the hospital with multiple medical problems COVID 19 causing acute tracheo-bronchitis/pharyngitis,  Atypical chest pain. Pt presented to the emergency room with cough, sore throat, fever, chest pain for about 3 days.  He was vaccinated for COVID-19.  His COVID-19 test was positive.  He was noted to have oxygen saturation now of 99% on room air.  He is afebrile.  Patient was seen and evaluated by IM and multiple consultants including ID, after a aggressive medical management patient has improved clinically feels better and ready for discharge. Patient has been cleared by ID to transition to p.o. OMNICEF/ Medrol Dosepak. No additional treatment indicated for COVID-19.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Pulmonary embolism
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM HYPOXIA
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA ANGINA, UNSPECIFIED
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Biopsy skin, Fungal infection, Rash, Skin discolouration
Clinical narrative: I started having issues with my skin. I have been getting fungus infections, and black dots that I have never had to deal with ever in my life. I made an appointment with my primary care physician who referred me to the dermatologist. The dermatologist removed two of the black spots, said that we need to keep an eye on the one spot. They gave me an antibiotic ointment for the skin fungus and my belly button.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Incorrect route of product administration, Injection site cellulitis, Injection site rash
Clinical narrative: Vaccine administer SQ in error- she had rash and cellulitis at injection site
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 1.0
Sex: F
Vaccine: IPV
Symptoms: Unevaluable event
Clinical narrative: no adverse reaction
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: ALLERGIC REACTION, INIT
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA 12/27/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure, Vascular pseudoaneurysm
Clinical narrative: J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/15/2023 PSEUDOANEURYSM, UNSPECIFIED SITE
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypercholesterolaemia, Neuropathy peripheral
Clinical narrative: PERIPHERAL NEUROPATHY 4/28/2023 HYPERCHOLESTEROLEMIA
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy blood vessel abnormal, Blood immunoglobulin E increased, Eosinophilic granulomatosis with polyangiitis, Hypersensitivity vasculitis, Neuropathy peripheral
Clinical narrative: One month after vaccine developed rash. Eventual biopsy with eosinophilic vasculitis., later neuropathy
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: One month after vaccine developed rash. Eventual biopsy with eosinophilic vasculitis., later neuropathy
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Deep vein thrombosis, Pulmonary embolism, Symptom recurrence
Clinical narrative: SADDLE PULMONARY EMBOLISM ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE DVT OF LEFT FEMORAL VEIN ACUTE PULMONARY EMBOLISM 11/9/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Embolic stroke
Clinical narrative: ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Idiopathic generalised epilepsy, Status epilepticus
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE EPILEPSY, GENERALIZED IDIOPATHIC STATUS EPILEPTICUS
Age: 37.0
Sex: M
Vaccine: HEP, HEPA, TDAP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Children's stock vaccine was given to an adult.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Haematochezia, Neuropathy peripheral
Clinical narrative: G62.9 NEUROPATHY 4/26/2023 OCCULT BLOOD IN STOOL
Age: 3.0
Sex: F
Vaccine: DTAP
Symptoms: Cellulitis, Contusion, Erythema, Induration, Skin warm
Clinical narrative: suspected cellulitis- given cephalexin.   red, warm to touch, hard.  spots turned up on other side of thigh as well, changed diagnosis from cellulitis to adverse reaction.  bruised.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Coagulopathy, Diarrhoea, Leukopenia
Clinical narrative: Pfizer vaccine was administered outside of facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED  COAGULOPATHY, UNSPECIFIED TYPE 3/20/2023 DIARRHEA COAGULOPATHY, UNSPECIFIED TYPE 3/20/2023 ANEMIA COAGULOPATHY, UNSPECIFIED TYPE 3/20/2023 LEUKOPENIA
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI 12/12/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: HYPOXIA 11/14/2022 & 11/15/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 18.0
Sex: M
Vaccine: MMRV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Proquad was given to a 18 year old patient.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/15/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 3.0
Sex: F
Vaccine: DTPPVHBHPB, DTPPVHBHPB
Symptoms: Injection site rash
Clinical narrative: Mom reported that patient developed a rash on the thigh at the site where she was given Vaxelis.
Age: 44.0
Sex: M
Vaccine: HEP
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Patient received a Pediatric dose instead of an adult dose
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Menstruation irregular, Pulmonary embolism, Tinnitus, Ultrasound Doppler abnormal
Clinical narrative: In May 2021 patient reports tinnitus. She also reports that she developed a recurrent DVT/PE in August of 2022 and feels this is related to the vaccine. She also feels her menstrual periods were more irregular after the vaccine.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Symptom recurrence, Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 12/19/2022 &  2/10/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 15.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Gave expired vaccine
Age: 4.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Pt received wrong dose, should have gotten the blue cap Mod bivalent vaccine 0.25ml. Pt will need additional dose.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Hypotension, Nausea, Syncope
Clinical narrative: Pt arrived to clinic at 1328 for 11 year old vaccines. Confirmed with mom that pt will receive Tdap, Meningococcal A, and HPV vaccines. Mom present and confirmed. Tdap and MenQuadfi given in L deltoid; HPV given in R deltoid. Pt initially tolerated well, then had brief syncope episode with self arousal. MD notified of event. MD at bedside to assess patient. Pt had hypotension and nausea. No concerns for WOB. No other symptoms. Laid patient down on exam table. Blood pressure rechecked after 10 minutes and improved. Pt sat up, rechecked and improved. Pt awake and answering questions, stating that she feels better. Confirmed with MD, ok to discharge pt. Advised pt to let mom know if not feeling well again. Advised to call back with any further questions or concerns. Mom ok with discharge and agreed with plan.
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Cellulitis, Erythema, Skin warm
Clinical narrative: Left arm cellulitis-warmth and redness
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Musculoskeletal stiffness, Pain in extremity, Tendon sheath incision, Trigger finger
Clinical narrative: I started having pain in my middle and stiffness in my hands while I was trying to do my gardening. I had an appointment with my rheumatologist. She had ordered physical therapy, steroid shots. None of this helped. I was referred to a hand specialist where it was discovered that I had trigger finger and I had to have surgery to resolve the issue. I am now in recovery as it takes 8 to 10 weeks for recovery.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI 1/5/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Diabetic nephropathy, Pulmonary embolism
Clinical narrative: I26.99 ACUTE PULMONARY EMBOLISM 4/9/2023 DM 2 W RENAL MANIFESTATION
Age: 18.0
Sex: M
Vaccine: HPV9
Symptoms: Blood glucose normal, Dizziness, Eye movement disorder, Hypertension, Loss of consciousness
Clinical narrative: C/O DIZZINESS, AFTER HE PASSED OUT, EYES ROLLED BACK AND STARTED SHAKING FOR A FEW SECONDS.  STIFF TO TRUNK ARMS AND LEGS FOR A FEW SECONDS. NURSE OR PROVIDER DID NOT WITNESS SHAKING OR CONVULSION. BP WAS HIGH 16-/100, PULSE 95, R 35, O 95%, INITIAL GLU 65.  A REPEAT OF VITALS AFTER SPRITE INTAKE GLUCOSE 84, BP NORMALIZED TO 130/80 SENT TO ER FOR F/U. MOTHER STATES HISTORY OF PREVIOUS EPISODE CHILD REPORTED HE HAD LOSS OF CONSIOUSNESS AFTER DOSE #1 HPV BUT NOBODY WITNESS THE EPISODE.
Age: 18.0
Sex: M
Vaccine: HPV9
Symptoms: Musculoskeletal stiffness, Seizure, Tremor
Clinical narrative: C/O DIZZINESS, AFTER HE PASSED OUT, EYES ROLLED BACK AND STARTED SHAKING FOR A FEW SECONDS.  STIFF TO TRUNK ARMS AND LEGS FOR A FEW SECONDS. NURSE OR PROVIDER DID NOT WITNESS SHAKING OR CONVULSION. BP WAS HIGH 16-/100, PULSE 95, R 35, O 95%, INITIAL GLU 65.  A REPEAT OF VITALS AFTER SPRITE INTAKE GLUCOSE 84, BP NORMALIZED TO 130/80 SENT TO ER FOR F/U. MOTHER STATES HISTORY OF PREVIOUS EPISODE CHILD REPORTED HE HAD LOSS OF CONSIOUSNESS AFTER DOSE #1 HPV BUT NOBODY WITNESS THE EPISODE.
Age: 0.25
Sex: F
Vaccine: DTAPIPV
Symptoms: No adverse event
Clinical narrative: There was no adverse event or outcome with patient
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthma-chronic obstructive pulmonary disease overlap syndrome, Condition aggravated, Hypoxia
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/25/2023 ACUTE EXACERBATION OF ASTHMA COPD OVERLAP SYNDROME (ASTHMA W COPD) R09.02 HYPOXIA 4/25/2023 ACUTE EXACERBATION OF ASTHMA COPD OVERLAP SYNDROME (ASTHMA W COPD)
Age: 16.0
Sex: M
Vaccine: MENB
Symptoms: Blood test, Culture urine, Drooling, Gait disturbance, Gait inability
Clinical narrative: Gait weakness, unable to walk, drooling starting on 5/1/23, IVIG started d/t possible AIDP per Brighton Criteria with mild improvement of symptoms.
Age: 16.0
Sex: M
Vaccine: MENB
Symptoms: Immunoglobulin therapy, Lumbar puncture, Magnetic resonance imaging
Clinical narrative: Gait weakness, unable to walk, drooling starting on 5/1/23, IVIG started d/t possible AIDP per Brighton Criteria with mild improvement of symptoms.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/17/2022,  11/22/2022,  11/14/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 14.0
Sex: M
Vaccine: PNC13
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Prevnar 13 was not ordered, but was administered on May 30th, 2023.  No symptoms or treatment required. patient guardian was contacted by physician.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Nasopharyngitis, No adverse event, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: I did not have an adverse reaction to the vaccine. I developed a bad cold in 05/2023. I tested for COVID-19 was negative in 05/2023. I had a telehealth visit with my doctor, and it was determined that a bad cold. I had a sore throat, runny nose and a bad cough. The symptoms lasted for about 14 days. I stayed hydrated and I took antihistamine, but it really didn't help. I tried too just tough it out.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: I did not have an adverse reaction to the vaccine. I developed a bad cold in 05/2023. I tested for COVID-19 was negative in 05/2023. I had a telehealth visit with my doctor, and it was determined that a bad cold. I had a sore throat, runny nose and a bad cough. The symptoms lasted for about 14 days. I stayed hydrated and I took antihistamine, but it really didn't help. I tried too just tough it out.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Impaired work ability, Malaise, Nasopharyngitis
Clinical narrative: Covid Breakthrough in January. Felt like a cold, super tired, my doctor prescribed paxlovid. I was very sick. I couldnt work for almost 2 weeks.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid Breakthrough in January. Felt like a cold, super tired, my doctor prescribed paxlovid. I was very sick. I couldnt work for almost 2 weeks.
Age: 59.0
Sex: F
Vaccine: TDAP
Symptoms: Expired product administered
Clinical narrative: Vaccine had expired on 4/22/23.
Age: 12.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: PATIENT HAD SCHEDULE FOR MENINGITIS WITHOUT SPECIFYING WHICH ONE. AFTER ADMINSTERING TRUMENBA HER FATHER SHOWED ME A TEXT FROM SCHOOL REQUIRING HER TO GET MENVEO
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE RESPIRATORY FAILURE 11/22/2022,  12/22/2022,  3/14/2023,  2/6/2023,  1/5/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 67.0
Sex: F
Vaccine: PNC20
Symptoms: Burning sensation, Pain in extremity, Pruritus
Clinical narrative: Patient complaints of left arm itching, burning, and pain after receiving dosage of vaccination
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXEMIA
Age: 79.0
Sex: M
Vaccine: PNC20, VARZOS
Symptoms: Pain
Clinical narrative: Patient states that he had pain in the first days after vaccination, ranging up to an 8 out of 10. He is still having pain now, over a month later, but it is less severe. If his arm is at rest, he has no pain up to a 1 out of 10. When using his arm, especially lifting it up, he has pain described as a 5 out of 10. He has taken ibuprofen and used ice, to some result. He was seen by his doctor, who noted that there is no swelling, redness, infection, or anything else notable.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Pneumonia
Clinical narrative: HYPOTENSION 11/7/2022 PNEUMONIA
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoxia
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXIA
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines  Pfizer 2/25/21 lot# EN6202;  Pfizer 3/18/21 lot# EN6207;  Pfizer 6/29/22 lot# FM0173;  Moderna 1/23/23 lot# AS7148B
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccine  MOderna 3/12/21 lot# 002B21A;  Moderna 4/8/21 lot# 025B21A
Age: 30.0
Sex: M
Vaccine: HEPA
Symptoms: Expired product administered
Clinical narrative: Vaccine was expired.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines ; mOderna 2/4/21 lot# 013M20A;  Moderna 3/4/21 lot# 030A21A;  MOderna 11/8/21 lot# 004F21A;  Moderna 5/16/22 lot# 038A22A;  Moderna 10/20/22 lot# 062F22A
Age: 96.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 10/15/21 lot# 301258A;  Pfizer 4/9/22 Lot# FK9895;  Pfizer 10/6/22 lot# GH9703
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines Moderna 3/17/21 lot# 002B21A;  Moderna 4/14/21 lot# 037B21A;  Moderna 11/22/21 lot# 004F21A;  Moderna 6/25/22 lot# 060A22A;  Moderna 10/12/22 lot# 062F22A
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE STABLE ANGINA
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Patient presented to the ED on 5/24/23 with shortness of breath. Tested positive for COVID. She was treated and discharged from the hospital on 5/28/23.
Age: 52.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Asthenia, Blood test, Chills, Decreased appetite, Dizziness
Clinical narrative: States on 6/6/23 he began to feel warm without fever, chilled, and would get cold easily.  Has had nausea and vomiting for several months due to gastritis,.  Has been losing weight but has been walking.  Has had decrease appetite past 2 - 3 weeks.  Three to four days ago no energy, tiredness, and dizziness. Due to concern for other illness, he went to his PMD in May who ran blood tests.  States his WBC was low and he had read that low WBC could be caused by the Jynneos vaccine.  Has had additional testing and follow up blood work by PMD for the additional health concerns, unrelated to vaccine.  Explained symptoms presenting today are common with Jynneos, and as a live vaccine would not be unexpected a week to 10 days following vaccination.  That is unaware of decreased WBC following vaccine, asked source of comment, unable to find source during conversation.  States, his WBC count was "just a little low".  Encouraged to follow up c PMD for the additional hear concerns, monitor symptoms, if worsen or no improvement by end of week 12 - 16, to seek additional care. Voiced understanding.
Age: 52.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Fatigue, Feeling cold, Feeling hot, Full blood count, Gastritis
Clinical narrative: States on 6/6/23 he began to feel warm without fever, chilled, and would get cold easily.  Has had nausea and vomiting for several months due to gastritis,.  Has been losing weight but has been walking.  Has had decrease appetite past 2 - 3 weeks.  Three to four days ago no energy, tiredness, and dizziness. Due to concern for other illness, he went to his PMD in May who ran blood tests.  States his WBC was low and he had read that low WBC could be caused by the Jynneos vaccine.  Has had additional testing and follow up blood work by PMD for the additional health concerns, unrelated to vaccine.  Explained symptoms presenting today are common with Jynneos, and as a live vaccine would not be unexpected a week to 10 days following vaccination.  That is unaware of decreased WBC following vaccine, asked source of comment, unable to find source during conversation.  States, his WBC count was "just a little low".  Encouraged to follow up c PMD for the additional hear concerns, monitor symptoms, if worsen or no improvement by end of week 12 - 16, to seek additional care. Voiced understanding.
Age: 52.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Nausea, Vomiting, Weight decreased, White blood cell count decreased
Clinical narrative: States on 6/6/23 he began to feel warm without fever, chilled, and would get cold easily.  Has had nausea and vomiting for several months due to gastritis,.  Has been losing weight but has been walking.  Has had decrease appetite past 2 - 3 weeks.  Three to four days ago no energy, tiredness, and dizziness. Due to concern for other illness, he went to his PMD in May who ran blood tests.  States his WBC was low and he had read that low WBC could be caused by the Jynneos vaccine.  Has had additional testing and follow up blood work by PMD for the additional health concerns, unrelated to vaccine.  Explained symptoms presenting today are common with Jynneos, and as a live vaccine would not be unexpected a week to 10 days following vaccination.  That is unaware of decreased WBC following vaccine, asked source of comment, unable to find source during conversation.  States, his WBC count was "just a little low".  Encouraged to follow up c PMD for the additional hear concerns, monitor symptoms, if worsen or no improvement by end of week 12 - 16, to seek additional care. Voiced understanding.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Imaging procedure, Laboratory test normal, Seizure like phenomena
Clinical narrative: per mom, on airplane for vacation and had seizure like activity, was evaluated at the ED and all testing was normal
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 2/20/21 lot# 023M20A;  Moderna 3/20/21 lot# 002B21A;  Moderna 11/11/21 lot# 058F21A;  MOderna 7/12/22 Lot# 017B22A
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site swelling, Pain, Peripheral swelling, Pyrexia
Clinical narrative: swelling and soreness at admin site; fever aches for 12 hours that evening; large swelling in arm pit for 5 additional days
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 75y.o. male presents to the ED for progressively worsening shortness of breath after testing positive for COVID.  Symptoms are associated with symptoms of shortness of breath that have improved slightly with breathing treatments.  Patient contacted his primary care physician who advised him to come immediately to the emergency department..
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Cerebrovascular accident
Clinical narrative: ACUTE NON ST ELEVATION MI ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Flank pain, SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: Presented to the hospital on 5/17/23 with flank pain, cough, and yellow sputum. Tested positive for COVID. He was treated and discharged on 6/2/23.
Age: 13.0
Sex: M
Vaccine: VARCEL
Symptoms: Dyspnoea, Food refusal, Papule, Pruritus, Pyrexia
Clinical narrative: Itchy red papules on arms and trunk.  Plaques on legs.  Mom states previous fever has resolved.  She says he is refusing to eat and seems to have more difficulty breathing (he is non-verbal).  He was seen in ER and prescribed prednisone and cetirizine lotion, but mom says he is not improved and is bringing back for re-evaluation.
Age: 13.0
Sex: M
Vaccine: VARCEL
Symptoms: Speech disorder
Clinical narrative: Itchy red papules on arms and trunk.  Plaques on legs.  Mom states previous fever has resolved.  She says he is refusing to eat and seems to have more difficulty breathing (he is non-verbal).  He was seen in ER and prescribed prednisone and cetirizine lotion, but mom says he is not improved and is bringing back for re-evaluation.
Age: 29.0
Sex: M
Vaccine: HEP
Symptoms: Erythema, Swelling face, Throat irritation, Urticaria
Clinical narrative: Vaccination was given at 0700, employee began experiencing symptoms approximately at 0830 and were hives, facial swelling and redness and scratchy throat.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Death, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient presented to the hospital on 4/26/23 with generalized weakness. During his admission, he began to develop fevers and tested positive for COVID on 5/3/23. The patient passed away in the hospital on 5/15/23.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Cough, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 on 5/20/23. I had sore throat, chills, and a cough. I contacted my doctor and was prescribed Paxlovid. My symptoms went away fast except my cough, it lingered for about 2 weeks.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Blood magnesium, Blood thyroid stimulating hormone, Borrelia test, C-reactive protein
Clinical narrative: Diagnosed with Acute Myocarditis (unspecified Myocarditis type) on 9 June 2023 after experiencing flu-like symptoms for 3 days.  Received chest X-ray, CT angiogram, CBC, Echocardiogram, ECG, and ekg.  Received 100mg doxycycline, 15mg Toreador, and discharged with 14 days of doxycycline.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Echocardiogram, Electrocardiogram, Fibrin D dimer, Full blood count
Clinical narrative: Diagnosed with Acute Myocarditis (unspecified Myocarditis type) on 9 June 2023 after experiencing flu-like symptoms for 3 days.  Received chest X-ray, CT angiogram, CBC, Echocardiogram, ECG, and ekg.  Received 100mg doxycycline, 15mg Toreador, and discharged with 14 days of doxycycline.